Clinical Pathology: Comprehensive Notes on Parasitic Protozoa

General Overview of Protozoa

  • Definition and Basic Structure: Protozoa are unicellular organisms. While many species are free-living, several are parasitic and of clinical significance in pathology.
  • Taxonomic Classification: They are divided into several phyla, primarily distinguished by their specific mechanisms of movement:     * Flagellated Protozoans: Utilize flagella for movement.     * Ameboid Protozoans: Utilize pseudopodia for movement.     * Apicomplexans (Sporozoa): Utilize internal locomotory organelles.     * Ciliated Protozoans: Utilize cilia for movement.

Essential Protozoology Terminology

  • Trophozoite: Refers to the moving or motile form of the protozoa.
  • Oocyst: Represents the fertilized egg stage that is typically shed within the feces of the host.
  • Sporozoite: The motile, infective form of the parasite.
  • Flagellum: A long, whiplike appendage used for locomotion.

Major Groups of Protozoa by Movement

Flagellates

  • Morphology: Possess at least 11 flagellum in the trophozoite stage. They are often shaped like a pear or a bullet.
  • Locomotion: The flagellum enables movement through liquid environments.
  • Habitat: Primarily reside in the liquid portions of the host’s body, such as the blood and various bodily fluids.
  • Common Examples:     * Giardia     * Leishmania     * Tritrichomonas

Amoebae

  • Locomotion: Move via pseudopodia, which are often referred to as "false feet."
  • Physical Appearance: Amorphous, poorly defined, or "blob-like" in shape.
  • Life Cycle Forms:     * Trophozoite: The motile, active form found in liquid media.     * Resistant Cyst: The inactive, protective form found in the soil or general environment.

Ciliates

  • Locomotion: Covered in cilia, which are tiny, short hairs that facilitate movement.
  • Life Cycle Forms:     * Motile Trophozoite: Known for its ability to "dart and twirl" in liquid media.     * Resistant Cyst: Provides survival capabilities in adverse external environmental conditions.

Apicomplexa

  • Complexity: Considered the most diverse and complicated group of protozoa.
  • Host Range: Capable of affecting virtually every type of animal.
  • Movement Characteristics: These organisms do not move extensively. They lack external locomotory structures but possess internal locomotory organelles not visible to the naked eye. Movement occurs via undulations.
  • Shape: Typically banana or boomerang-shaped.
  • Common Examples:     * Toxoplasma     * Cryptosporidium     * Babesia     * Hepatozoon

Giardia spp. (Flagellate)

Biology and Hosts

  • Primary Location: Small intestine of various mammals.
  • Infected Species: Dogs, cats, ruminants, pigs, horses, and primates.
  • Prepatent Period (PPP): 11 week.
  • Zoonotic Status: Possesses zoonotic potential, specifically via "Assemblage A," which can affect humans, dogs, and cats.

Clinical Signs

  • Young Animals: Soft stools and chronic diarrhea. Stools often have high fat content (malabsorption) and appear mucoid.
  • Adult Animals: Often asymptomatic carriers.
  • General Symptoms: Diarrhea, weight loss, vomiting, and dehydration.

Diagnostic Morphology and Testing

  • Diagnostic Forms:     * Giardia Trophozoite: The motile form.     * Giardia Cyst: The dormant form, measuring approximately 8−10 μm8-10\,\mu m.
  • Testing Methods:     * Fecal Flotation: Standard diagnostic tool.     * Direct Smear: Used for immediate visualization.     * Direct Fluorescent Antibody (DFA): Recognized as the Gold Standard.     * Polymerase Chain Reaction (PCR): Highly sensitive and specific (99%99\%).     * Enzyme-Linked Immunosorbent Assay (ELISA): Fast and convenient protocol (96%96\%).
  • Clinical Note: Cyst shedding is inconsistent. Best practices involve combination testing and obtaining several samples over different days.

Life Cycle and Transmission

  1. Cysts are immediately infectious upon being shed.
  2. Consumption occurs via contaminated food or water.
  3. Excystation: Once consumed, cysts release 22 trophozoites.
  4. Attachment: Trophozoites attach to the mucosa of the small intestine to absorb nutrients.
  5. Multiplication: Trophozoites divide through longitudinal binary fission.
  6. Encystation: As they move toward the colon, they transform back into cysts. Both forms (cysts and trophozoites) may be present in the stool.

Treatment

  • Pharmacology: Fenbendazole, Metronidazole, or a combination of the two.
  • Supportive Care: Necessary for animals suffering from dehydration.

Tritrichomonas foetus ("Trich")

Morphology and Survival

  • Structure: Possesses 33 flagella at the anterior end and 11 flagellum at the posterior end.
  • Movement: Described as not a "smooth mover," characterized by rolling and abrupt directional changes.
  • Hardiness: Can survive freezing temperatures but is killed by high heat and drying.

Bovine Tritrichomoniasis

  • Habitat: Genital tracts of cattle; primarily beef cattle, though dairy breeds are susceptible.
  • Anatomy: Found in the cervix of cows and preputial mucosa of bulls.
  • Transmission: A venereal disease transmitted during mating.
  • Infection Duration: Most cows clear the infection within 33 months (but can be reinfected), whereas bulls can remain infected indefinitely.
  • Clinical Signs in Cattle:     * Bulls: Usually asymptomatic.     * Cows: Infertility, early embryonic death, cows appearing "open" (not pregnant) despite being bred, pyometra, endometritis, and mummified fetuses. Abortions are less common.
  • Diagnosis: Culture of bull prepuce scrapes (bulls are the primary carriers); vaginal discharge culture in cows is less common.
  • Treatment: No proven safe pharmaceutical treatment exists. The primary strategy is to cull infected bulls. Bulls require repeated sampling to confirm negative status.     * Dimetridazole: Can safely kill T. foetusT.\,foetus in semen.     * Metronidazole: Used for human Trichomonas vaginalis; currently prohibited for off-label use in food animals.     * Vaccines: Developed but found to be ineffective.

Feline Tritrichomonosis

  • Etiology: Different strains (genotypes) found in the GI tract of cats.
  • Susceptibility: Cats less than 11 year old are highly susceptible.
  • Clinical Signs: Colitis and chronic diarrhea containing blood and mucus. Symptoms often wax and wane.
  • Transmission: Fecal-oral route, prevalent in high-density environments like shelters or catteries.
  • Diagnosis: Rectal swabs or fecal samples sent for specialized culture.

Toxoplasma gondii (Coccidia Type)

Host Dynamics and Zoonosis

  • Definitive Host: Felines (parasite resides in the small intestine).
  • Intermediate Host: "All of the things" (broad range of mammals and birds).
  • Zoonotic Disease: Causes Toxoplasmosis.
  • Prepatent Period (PPP): 5−245-24 days.

Life Cycle Details

  1. Unsporulated oocysts are shed in feline feces.
  2. Sporulation: Oocysts sporulate in the environment over 1−51-5 days to become infective.
  3. Intermediate Infection: Host ingests sporulated oocysts from contaminated soil, water, or plants. Oocysts encyst in muscle tissue.
  4. Feline Infection: Cats are infected by ingesting sporulated oocysts or intermediate hosts containing tissue cysts.
  5. Internal Development: Parasite is released in the GI tract. Some penetrate the intestinal wall to form cysts/clones, spreading to other tissues.
  6. Transformations: Within tissues, they transform into tachyzoites and later bradyzoites (tissue cysts).

Clinical Signs

  • Intestinal (Cats): Often asymptomatic.
  • Tissue Infection: Asymptomatic in light cases; severe in immunocompromised hosts (fever, weight loss, lethargy).
  • CNS Involvement: Most likely tissue to exhibit clinical signs.
  • Reproductive Impact: Can cause abortion in mammals; congenital infection leads to neurologic disease, birth defects, stillbirth, and ocular disease (especially in humans, sheep, and goats).

Diagnostics

  • Common Tests: Feline fecal flotation, blood or serum tests.
  • Oocyst Characteristics: Size is approximately 10−12 μm10-12\,\mu m.

Cryptosporidium (Coccidia Type)

Hosts and Biology

  • Definitive Hosts: Specialized for calves, canines, felines, bovines, ovines, swine, avians, guinea pigs, snakes, and mice.
  • Location: Small intestine; also stomach/abomasum in snakes, mice, and cattle.
  • Physical Size: Extremely small oocysts (3−5 μm3-5\,\mu m), requiring specialized microscopy for visualization.

Life Cycle and Transmission

  • Transmission: Contact with fecally contaminated water (drinking/recreational) or food.
  • Development: Released sporozoites parasitize epithelial cells in the GI or respiratory tract.
  • Multiplication: Occurs via asexual multiplication followed by sexual multiplication (male and female parasites).
  • Oocyst Types:     * Thick-walled Oocysts: Shed in feces and remain infective upon excretion.     * Thin-walled Oocysts: Remain in the host for auto-reinfection of tissues.

Clinical Care and Testing

  • Clinical Signs: Profuse watery diarrhea and abdominal pain.
  • Treatment: No known specific pharmacological treatment; supportive therapy is used to prevent dehydration.
  • Testing:     * Fecal Flotation: Oocysts are easily missed due to size.     * Direct Smear: Requires acid-fast staining for identification.     * ELISA: Enzyme-linked tests used for detection.

Babesia canis (Hemoprotozoa)

Host and Vector Relationship

  • Definitive Host: Canine.
  • Intermediate Host: Tick.
  • Vector Dynamics: Ticks require attachment for 24−4824-48 hours to transmit the parasite. Prevalent in the southern United States.

Life Cycle

  1. Ticks release sporozoites from their saliva into the dog's bloodstream during feeding.
  2. Sporozoites invade erythrocytes (red blood cells/RBCs).
  3. Parasites multiply and rupture the RBCs, releasing stages to infect new cells.
  4. Ticks become infected by consuming Babesia-infected blood meals.

Diagnosis and Clinical Presentation

  • Clinical Signs: Moderate to severe hemolytic anemia, fever, anorexia, pallor, and a bounding pulse.
  • Diagnosis: Identification of pear-shaped parasites within RBCs on blood smears; PCR testing (lab-based blood test).
  • Treatment: Imidocarb dipropionate (antiprotozoal), Doxycycline, and Metronidazole.
  • Prognosis Note: Treatment reduces clinical signs and parasite load, but the dog remains a carrier for life.
  • Prevention: Strict tick control.